User profiles for W.Y. Lau

Lau WY

The Chinese University of Hong Kong
Verified email at cuhk.edu.hk
Cited by 58262

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)

…, HA Pitt, H Singh, ACW Chan, WY Lau… - Journal of Hepato …, 2018 - Wiley Online Library
The Tokyo Guidelines 2013 (TG13) for acute cholangitis and cholecystitis were globally
disseminated and various clinical studies about the management of acute cholecystitis were …

Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)

…, C Dervenis, ACW Chan, WY Lau… - Journal of Hepato …, 2018 - Wiley Online Library
Although the diagnostic and severity grading criteria on the 2013 Tokyo Guidelines ( TG 13)
are used worldwide as the primary standard for management of acute cholangitis ( AC ), …

[HTML][HTML] TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos)

…, Y Yamashita, C Dervenis, ACW Chan, WY Lau… - Journal of hepato-biliary …, 2013 - Springer
Since its publication in 2007, the Tokyo Guidelines for the management of acute cholangitis
and cholecystitis (TG07) have been widely adopted. The validation of TG07 conducted in …

Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial

…, JFY Lee, RYC Yiu, SSM Ng, PBS Lai, WY Lau - The Lancet, 2004 - thelancet.com
… KL Leung, PY Kwok, and WY Lau designed the study, wrote the protocol, and supervised
the study. KL Leung was the principal investigator; he designed the study proforma and the …

Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial

WY Lau, TWT Leung, SKW Ho, M Chan, D Machin… - The Lancet, 1999 - thelancet.com
WY Lau did all the hepatic resections. TWT Leung was the overall coordinator and … J Lau
was the internal statistics reviewer and monitor. ATC Chan, W Yeo, TSK Mok, and NWY Leung …

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

…, RP Guo, HH Liang, YQ Zhang, XJ Lin, WY Lau - 2006 - journals.lww.com
Objective: To compare the results of percutaneous local ablative therapy (PLAT) with surgical
resection in the treatment of solitary and small hepatocellular carcinoma (HCC). Summary …

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and …

…, B Zee, WY Lau, PBS Lai, KL Leung, JTF Lau… - Cancer, 2002 - Wiley Online Library
BACKGROUND The current TNM staging system for patients with hepatocellular carcinoma
(HCC) does not include liver function parameters and does not provide a precise prognosis …

A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular …

…, B Zee, TWT Leung, PBS Lai, WY Lau… - Journal of the …, 2005 - academic.oup.com
Background: Single-agent doxorubicin has been widely used to treat unresectable
hepatocellular carcinoma (HCC), but the response rate is low (<20%) and there is no convincing …

Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients

…, CT Liew, MHL Ng, N Wong, PBS Lai, WY Lau… - Cancer research, 1999 - AACR
We have studied the feasibility of detecting tumor-associated aberrant p16 methylation in
the circulation of patients with hepatocellular carcinoma (HCC). We extracted DNA from the …

Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis

…, ACW Chan, SCS Chung, WY Lau - British journal of …, 1998 - Wiley Online Library
Background The aim of this prospective randomized study was to define the optimum
management between early and delayed laparoscopic cholecystectomy for patients with acute …